Get started
DBV TECHNOLOGIES SADBV TECHNOLOGIES SADBV TECHNOLOGIES SA

DBV TECHNOLOGIES SA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

DBV chart


Full chart

DBV upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪63.30 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.98 EUR
Net income (FY)
‪−67.27 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪79.63 M‬
Beta (1Y)
0.58

Employees


Employees (FY)
104
Change (1Y)
+19 +22.35%
Revenue / Employee (1Y)
0.00 EUR
Net income / Employee (1Y)
‪−713.92 K‬ EUR

About DBV TECHNOLOGIES


Sector
Health Technology
CEO
Daniel Tassé
Headquarters
Chatillon
Website
dbv-technologies.com
Founded
2002
ISIN
FR0010417345
FIGI
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

DBV news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DBV is 0.60 EUR — it has decreased by −4.26% in the past 24 hours. Watch DBV TECHNOLOGIES SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange DBV TECHNOLOGIES SA stocks are traded under the ticker DBV.
DBV stock has fallen by −18.08% compared to the previous week, the month change is a −8.03% fall, over the last year DBV TECHNOLOGIES SA has showed a −63.09% decrease.
We've gathered analysts' opinions on DBV TECHNOLOGIES SA future price: according to them, DBV price has a max estimate of 6.48 EUR and a min estimate of 2.46 EUR. Watch DBV chart and read a more detailed DBV TECHNOLOGIES SA stock forecast: see what analysts think of DBV TECHNOLOGIES SA and suggest that you do with its stocks.
DBV reached its all-time high on Jan 19, 2021 with the price of 13.28 EUR, and its all-time low was 0.62 EUR and was reached on Oct 2, 2024. View more price dynamics on DBV chart.
See other stocks reaching their highest and lowest prices.
DBV stock is 5.88% volatile and has beta coefficient of 0.58. Track DBV TECHNOLOGIES SA stock price on the chart and check out the list of the most volatile stocks — is DBV TECHNOLOGIES SA there?
Today DBV TECHNOLOGIES SA has the market capitalization of ‪63.21 M‬, it has decreased by −14.40% over the last week.
Yes, you can track DBV TECHNOLOGIES SA financials in yearly and quarterly reports right on TradingView.
DBV TECHNOLOGIES SA is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
DBV earnings for the last quarter are −0.30 EUR per share, whereas the estimation was −0.33 EUR resulting in a 9.86% surprise. The estimated earnings for the next quarter are −0.29 EUR per share. See more details about DBV TECHNOLOGIES SA earnings.
DBV TECHNOLOGIES SA revenue for the last quarter amounts to ‪1.02 M‬ EUR, despite the estimated figure of ‪1.04 M‬ EUR. In the next quarter, revenue is expected to reach ‪1.04 M‬ EUR.
DBV net income for the last quarter is ‪−27.71 M‬ EUR, while the quarter before that showed ‪−30.76 M‬ EUR of net income which accounts for 9.92% change. Track more DBV TECHNOLOGIES SA financial stats to get the full picture.
No, DBV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 15, 2024, the company has 104.00 employees. See our rating of the largest employees — is DBV TECHNOLOGIES SA on this list?
Like other stocks, DBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DBV TECHNOLOGIES SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DBV TECHNOLOGIES SA technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DBV TECHNOLOGIES SA stock shows the strong sell signal. See more of DBV TECHNOLOGIES SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.